{"id":7587,"date":"2019-01-31T15:01:22","date_gmt":"2019-01-31T15:01:22","guid":{"rendered":"https:\/\/www.nicox.com\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/"},"modified":"2019-01-31T15:01:22","modified_gmt":"2019-01-31T15:01:22","slug":"participation-de-nicox-au-glaucoma-360-new-horizons-forum","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/","title":{"rendered":"Participation de Nicox au Glaucoma 360 New Horizons Forum"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Sophia Antipolis, France<\/p>\n<p>Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce que le Dr. Tomas Navratil, <em>Executive Vice President, Head of Development<\/em> de Nicox, fera une pr\u00e9sentation au <em>Glaucoma 360 New Horizons Forum<\/em>, organis\u00e9e par la <em>Glaucoma Research Foundation,<\/em> le 1er f\u00e9vrier 2019 \u00e0 13 :22 heure locale, soit 22:22 heure de Paris. Sa pr\u00e9sentation se tiendra lors de la session <em>New Horizons in Drugs and Drops<\/em>.<\/p>\n<p>La conf\u00e9rence se tiendra au Palace Hotel \u00e0 San Francisco, Etats-Unis.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce que le Dr. Tomas Navratil, Executive Vice President, Head of Development de Nicox, fera une pr\u00e9sentation au Glaucoma 360 New Horizons Forum, organis\u00e9e par la Glaucoma Research Foundation, le 1er f\u00e9vrier 2019 \u00e0 13 :22 heure locale, [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7587","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text]Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce que le Dr. Tomas Navratil, Executive Vice President, Head of Development de Nicox, fera une pr\u00e9sentation au Glaucoma 360 New Horizons Forum, organis\u00e9e par la Glaucoma Research Foundation, le 1er f\u00e9vrier 2019 \u00e0 13 :22 heure locale, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-31T15:01:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Participation de Nicox au Glaucoma 360 New Horizons Forum\",\"datePublished\":\"2019-01-31T15:01:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/\"},\"wordCount\":108,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/\",\"name\":\"Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2019-01-31T15:01:22+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/","og_locale":"fr_FR","og_type":"article","og_title":"Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox","og_description":"[vc_row][vc_column][vc_column_text]Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce que le Dr. Tomas Navratil, Executive Vice President, Head of Development de Nicox, fera une pr\u00e9sentation au Glaucoma 360 New Horizons Forum, organis\u00e9e par la Glaucoma Research Foundation, le 1er f\u00e9vrier 2019 \u00e0 13 :22 heure locale, [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/","og_site_name":"Nicox","article_published_time":"2019-01-31T15:01:22+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/"},"author":{"name":"","@id":""},"headline":"Participation de Nicox au Glaucoma 360 New Horizons Forum","datePublished":"2019-01-31T15:01:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/"},"wordCount":108,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/","url":"https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/","name":"Participation de Nicox au Glaucoma 360 New Horizons Forum - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2019-01-31T15:01:22+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/participation-de-nicox-au-glaucoma-360-new-horizons-forum\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7587"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}